Growing Product Portfolio Troikaa consistently expands its offerings with innovative formulations like Zolpidem Sublingual Spray and advanced NSAID sprays, indicating opportunities to collaborate on novel delivery systems and niche therapeutic areas.

Market Expansion Potential The company’s recent product launches in India and overseas markets suggest a readiness to explore new geographical regions and therapeutic segments, making it a promising partner for market entry and distribution channels.

Investing in Innovation Troikaa’s focus on launching advanced pharmaceutical products demonstrates a commitment to innovation, opening doors for suppliers of cutting-edge manufacturing technology, packaging solutions, and R&D collaborations.

Robust Manufacturing Capacity With three state-of-the-art facilities and over 2300 employees, Troikaa offers substantial manufacturing expertise, creating opportunities for partnership in supply chain optimization, raw materials, and OEM manufacturing services.

Financial Growth Signals Generating between $250M and $500M in revenue, Troikaa presents potential sales opportunities aligned with growing demand for specialty pharmaceuticals, especially in pain management and sleep disorder markets.